SNGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. SNGX is in a clear short-to-medium term downtrend (bearish moving averages and worsening MACD) and there are no Intellectia trading signals to justify an impatient entry. With price sitting near key supports (around 1.268/1.216) after a sharp -5.73% regular-session drop, the setup is more “catching a falling knife” than a high-conviction buy.
Trend: Bearish. The moving average stack is negative (SMA_200 > SMA_20 > SMA_5), showing sustained downside momentum. Momentum: MACD histogram is below zero (-0.00784) and negatively expanding, indicating weakening momentum and increasing downside pressure. RSI: RSI_6 = 30.877, near oversold but still labeled neutral here—this can allow a bounce, but it is not a standalone buy signal. Levels: Current price 1.2399 is below S1 (1.268) and approaching S2 (1.216). Resistance is overhead at pivot 1.352 then 1.436. For a “buy now” case, you’d typically want price to reclaim ~1.268 and then pivot 1.352; otherwise rallies are likely to be sold. Intellectia signals: AI Stock Picker = no signal; SwingMax = no recent signal, so there is no system-backed edge indicating today is the low-risk entry.
Pattern-based projection indicates a probabilistic upside bias (80% chance to +2.28% next day, +3.19% next week, +8.67% next month), suggesting a potential short-term mean-reversion bounce.
Pre-market is modestly positive (+1.53%), which sometimes precedes a relief rebound after a heavy red session.
Price is near support (1.216–1.268), where buyers may attempt to defend.
and MACD downside is expanding—conditions that often persist.
Latest quarter: 2025/Q3. Revenue: 0 (no YoY improvement; reported as up 0.00% YoY). Net income: -2,530,947 (loss narrowed vs. last year; improved 47.20% YoY). EPS: -0.58 (worsened -25.64% YoY). Overall: Still a loss-making profile with no revenue; while net loss improved, EPS deterioration and lack of top-line traction weaken the near-term fundamental buy case.
No analyst rating or price target change data was provided, so no recent trend can be confirmed. Wall Street-style view (inferred from available data only): Pros: Potential for technical rebound near support; loss narrowing YoY. Cons: No revenue, ongoing losses, and bearish technical trend with no proprietary buy signals—insufficient evidence for a high-conviction buy today. Politicians / influential figures: No recent congress trading data available in the last 90 days (no confirmed buys or sells). Congress trading assessment: No data to interpret.
